Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 (IFM2008)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01206205
Recruitment Status : Completed
First Posted : September 21, 2010
Last Update Posted : May 12, 2017
Celgene Corporation
Janssen-Cilag Ltd.
Information provided by (Responsible Party):
University Hospital, Toulouse